Health-related quality of life in patients with narcolepsy types 1 and 2 from a Sleep Center in Brazil [PDF]
Arquivos de Neuro-Psiquiatria, 2020 Introduction: Narcolepsy patients have higher prevalence of comorbidities, such as obesity, depression, and pain. Narcolepsy symptoms and concomitant medical conditions can impact the daily activities of patients.
Renata Carvalho CREMASCHI +3 more
doaj +1 more source
How are normal sleeping controls selected? A systematic review of cross-sectional insomnia studies, and a standardised method to select healthy controls for sleep research [PDF]
, 2008 There appears to be some inconsistency in how normal sleepers (controls) are selected and screened for participation in research studies for comparison with insomnia patients.
Louise Beattie +59 more
core +11 more sources
Autoimmunity and Immunotherapy in Narcolepsy [PDF]
Sleep Medicine Research, 2017 Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucination, and sleep paralysis. Narcolepsy is caused by damage of hypocretin producing neurons in the lateral hypothalamus.
Min Jae Seong, Seung Bong Hong
doaj +1 more source
Hypocretin Levels in Sporadic and Familial Cases of Canine Narcolepsy
Neurobiology of Disease, 2001 Familial and sporadic forms of narcolepsy exist in both humans and canines. Mutations in the hypocretin receptor 2 gene (Hcrtr 2) cause canine familial narcolepsy.
Beth Ripley +4 more
doaj +1 more source
Treatment dilemmas in a young man presenting with narcolepsy and psychotic symptoms. [PDF]
, 2011 Psychotic features can be present in both narcolepsy and psychosis, which can result in challenges in diagnosis and management. The prevalence of both conditions is low and the reports in young people are scarce. Our report illustrates the relevance of a
Davies, S, Fernandez, V, Walters, N
core +2 more sources
Recently Approved and Upcoming Treatments for Narcolepsy
CNS Drugs, 2020 Narcolepsy is a chronic, disabling neurologic disorder characterised by excessive daytime sleepiness (EDS) and, in up to 60% of patients, cataplexy. Treatments for narcolepsy are aimed at improving wakefulness (e.g.
M. Thorpy
semanticscholar +1 more source
Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home : an exploratory study [PDF]
, 2013 Background: Gamma-hydroxybutyric acid (GHB), well known as a party drug, especially in Europe, is also legally used (sodium oxybate, Xyrem (R)) to treat a rare sleep disorder, narcolepsy with cataplexy.
Hertegonne, Katrien +3 more
core +1 more source
Narcolepsy and psychosis: A systematic review
Acta Psychiatrica Scandinavica, 2021 Objective Narcolepsy is a rare sleep disorder in which psychotic‐like symptoms can present diagnostic and therapeutic challenges. We aimed to review the association between, and medical management of, narcolepsy and psychosis in children and adults ...
Cyril Hanin +6 more
semanticscholar +1 more source
A practical guide to the pharmacological and behavioral therapy of Narcolepsy
Neurotherapeutics, 2021 Narcolepsy is a rare, chronic, and disabling central nervous system hypersomnia; two forms can be recognized: narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2).
C. Franceschini +3 more
semanticscholar +1 more source
Science-in-brief: Clinical highlights from BEVA Congress 2016 [PDF]
, 2017 No abstract ...
Chauché, C., Kennedy, R.
core +1 more source